Lamotrigine Tablet, Chewable
Product Images NDC 65862-362

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Lamotrigine (NDC 65862-362). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Aurobindo Pharma Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Lamotrigine Tablets (chewable, Dispersible) (Lamotrigine Fig1)

Lamotrigine Tablets (chewable, Dispersible) (Lamotrigine Fig1)
The text describes a figure labeled as "Figure 1" showing the Kaplan-Meier estimation of cumulative proportion of patients with mood episode in Trial 1. The figure includes two lines labeled as "Placebo" and "LAMOTRIGINE" and a horizontal axis labeled as "Weeks". The graph shows the probability of having a mood episode over time, with percentages increasing until around week 8-10 and then remaining steady.*
FDA Label Image

Figure 1: Kaplan-meier Estimation Of Cumulative Proportion Of Patients With Mood Episode (trial 1) (Lamotrigine Fig2)

Figure 1: Kaplan-meier Estimation Of Cumulative Proportion Of Patients With Mood Episode (trial 1) (Lamotrigine Fig2)
The text is a figure caption showing the Kaplan-Meier Estimation of Cumulative Proportion of Patients with a Mood Episode in Trial 2. The figure compares the placebo group to the group taking LAMOTRIGINE. Not available to provide a further description as the image is necessary to understand this data.*
FDA Label Image

Figure 2: Kaplan-meier Estimation Of Cumulative Proportion Of Patients With Mood Episode (trial 2) (Lamotrigine Fig3)

Figure 2: Kaplan-meier Estimation Of Cumulative Proportion Of Patients With Mood Episode (trial 2) (Lamotrigine Fig3)
Lamotrigine Tablets for Oral Suspension are available in two strengths, 5mg and 25mg. The 5mg tablets are white to off-white and are marked with a "D" on one side. The 25mg tablets are also white to off-white with "D99" on one side and "98" on the other side. They have a plain surface on their another side.*
FDA Label Image

Package Label-principal Display Panel (5 mg (100 Tablets Bottle))

Package Label-principal Display Panel (5 mg (100 Tablets Bottle))
This is a description for Lamotrigine Tablets for Oral Suspension, USP. it is an Rx only medication that is distributed by Aurobindo Pharma USA, Inc. The usual dosage information can be found in the prescribing information. The tablets can be swallowed whole, chewed, or dispersed in water or diluted fruit juice. It's important not to accept the medication if the printed seal under the cap is missing or broken. It should be stored in a tight, light-resistant container as defined in the USP, at 20° to 25°C (68°to 77°F), with excursions permitted to 15° 10 30°C (69°to 86°F)[see USP Gontralled Room Temperature]. A medication guide should be dispensed to each patient.*
FDA Label Image

Package Label-principal Display Panel (5 mg Blister Carton (10 x 10 Unit-dose))

Package Label-principal Display Panel (5 mg Blister Carton (10 x 10 Unit-dose))
The text is promoting Lamotrigine Tablets for Oral Suspension, USP. Each tablet contains 5mg of Lamotrigine USP and can be taken as a whole or dispersed in water or diluted fruit juice. The dosage information is found in the prescribing information. It comes in a tightly sealed, light-resistant container and should be stored between 20°C to 25°C (68°F to 77°F) with excursions permitted between 15°C to 30°C (59°F to 86°F.) The medication guide should be dispensed to each patient. Distributed by Aurobindo Pharma USA, Inc. Made in India.*
FDA Label Image

Package Label-principal Display Panel (25 mg (100 Tablets Bottle))

Package Label-principal Display Panel (25 mg (100 Tablets Bottle))
This is a medication guide for Lamotrigine Tablets for Oral Suspension. Each tablet contains Lamotrigine USP 25 mg. The tablets can be swallowed whole, chewed, or dispersed in water or diluted juice. The medication guide should be distributed to each patient. This prescription medicine should only be used according to the prescribing information. The medicine comes in a tight, light-resistant container and should be stored at 20° to 25°C.*
FDA Label Image

Package Label-principal Display Panel (25 mg Blister Carton (10 x 10 Unit-dose))

FDA Label Image

Chemical Structure (Lamotrigine Str)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.